Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Morales

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
Thorax|October 5, 2016
Role of acid sphingomyelinase and IL-6 as mediators of endotoxin-induced pulmonary vascular dysfunctionRachele Pandolfi, Bianca Barreira, Enrique Moreno, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 18, 2026
The Sigma-1 receptor agonist PRE084 improves cardiopulmonary function and remodelling in an experimental model of pulmonary arterial hypertensionMarta Villegas-Esguevillas, Bianca Barreira, Ana Hernández-García, et al.
British Journal of Pharmacology|March 19, 2019
Activation of K<sub>v</sub> 7 channels as a novel mechanism for NO/cGMP-induced pulmonary vasodilationGema Mondéjar-Parreño, Javier Moral-Sanz, Bianca Barreira, et al.
Molecules (Basel, Switzerland)|December 22, 2016
Effects of Quercetin in a Rat Model of Hemorrhagic Traumatic Shock and ReperfusionVirginia Chamorro, Rachele Pandolfi, Laura Moreno, et al.
Frontiers in Pharmacology|April 17, 2023
Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat modelDaniel Morales-Cano, Jose Luis Izquierdo-García, Bianca Barreira, et al.
Frontiers in Pharmacology|June 28, 2023
Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat modelDaniel Morales-Cano, Jose Luis Izquierdo-García, Bianca Barreira, et al.
Biotechnology and Applied Biochemistry|September 24, 2020
Microbial prospection of communities that produce biosurfactants from the water column and sediments of the Gulf of MexicoDaniel Morales-Guzmán, Fernando Martínez-Morales, Brandt Bertrand, et al.
International Journal of Cardiology. Heart & Vasculature|February 23, 2023
Topography of immune cell infiltration in different stages of coronary atherosclerosis revealed by multiplex immunohistochemistryKimberley R G Cortenbach, Daniel Morales Cano, Jelena Meek, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 25, 2018
Ephexin1 Is Required for Eph-Mediated Limb Trajectory of Spinal Motor AxonsChih-Ju Chang, Ming-Yuan Chang, Szu-Yi Chou, et al.
Journal of the American Heart Association|July 25, 2019
Th2 CD4<sup>+</sup> T Cells Are Necessary and Sufficient for Schistosoma-Pulmonary HypertensionRahul Kumar, Claudia Mickael, Biruk Kassa, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
Thorax|October 5, 2016
Role of acid sphingomyelinase and IL-6 as mediators of endotoxin-induced pulmonary vascular dysfunctionRachele Pandolfi, Bianca Barreira, Enrique Moreno, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 18, 2026
The Sigma-1 receptor agonist PRE084 improves cardiopulmonary function and remodelling in an experimental model of pulmonary arterial hypertensionMarta Villegas-Esguevillas, Bianca Barreira, Ana Hernández-García, et al.
British Journal of Pharmacology|March 19, 2019
Activation of K<sub>v</sub> 7 channels as a novel mechanism for NO/cGMP-induced pulmonary vasodilationGema Mondéjar-Parreño, Javier Moral-Sanz, Bianca Barreira, et al.
Molecules (Basel, Switzerland)|December 22, 2016
Effects of Quercetin in a Rat Model of Hemorrhagic Traumatic Shock and ReperfusionVirginia Chamorro, Rachele Pandolfi, Laura Moreno, et al.
Frontiers in Pharmacology|April 17, 2023
Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat modelDaniel Morales-Cano, Jose Luis Izquierdo-García, Bianca Barreira, et al.
Frontiers in Pharmacology|June 28, 2023
Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat modelDaniel Morales-Cano, Jose Luis Izquierdo-García, Bianca Barreira, et al.
Biotechnology and Applied Biochemistry|September 24, 2020
Microbial prospection of communities that produce biosurfactants from the water column and sediments of the Gulf of MexicoDaniel Morales-Guzmán, Fernando Martínez-Morales, Brandt Bertrand, et al.
International Journal of Cardiology. Heart & Vasculature|February 23, 2023
Topography of immune cell infiltration in different stages of coronary atherosclerosis revealed by multiplex immunohistochemistryKimberley R G Cortenbach, Daniel Morales Cano, Jelena Meek, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 25, 2018
Ephexin1 Is Required for Eph-Mediated Limb Trajectory of Spinal Motor AxonsChih-Ju Chang, Ming-Yuan Chang, Szu-Yi Chou, et al.
Journal of the American Heart Association|July 25, 2019
Th2 CD4<sup>+</sup> T Cells Are Necessary and Sufficient for Schistosoma-Pulmonary HypertensionRahul Kumar, Claudia Mickael, Biruk Kassa, et al.
Pageof 15